文献速递血栓与止血

ABO O血型作为肝素诱导血小板减少症中血小板反应性的危险因素

ABO O blood group as a risk factor for platelet reactivity in heparin-induced thrombocytopenia.
PubMed 文献 · Blood · 2022-01-01

该研究在大规模发现队列中按功能试验阳性病例、抗体阳性对照和抗体阴性对照分组进行全基因组关联研究,并在复制队列中验证。发现rs8176719 C插入变异(编码所有非O血型等位基因)对功能试验阳性有保护作用,而O血型是HIT的危险因素(OR 1.42)。

要点

  • O血型是HIT的危险因素(OR 1.42,95%CI 1.26-1.61,P=3.09×10-8)。
  • rs8176719 C插入变异(非O血型)对功能试验阳性有保护作用。
  • ABO关联独立于PF4/肝素IgG水平。

核心结论

  • O血型是HIT的危险因素,rs8176719 C插入变异(非O血型)有保护作用。

研究设计与样本

  • 全基因组关联研究(GWAS),发现队列分为功能试验阳性病例(n=1269)、抗体阳性(功能试验阴性)对照(n=1131)和抗体阴性对照(n=1766)。
  • 复制队列包括功能试验确诊HIT病例(n=177)、抗体阳性(功能试验阴性)对照(n=258)和抗体阴性对照(n=351)。

主要发现

  • 功能试验阳性与PF4/肝素IgG水平升高相关(OR 16.53,95%CI 13.83-19.74,P=1.51×10-209),与女性性别相关(OR 1.15,95%CI 1.01-1.32,P=.034)。
  • rs8176719 C插入变异在发现队列中与功能试验阳性状态显著相关(频率=0.41;OR 0.751,95%CI 0.682-0.828,P=7.80×10-9)。
  • rs8176719 C插入变异在复制队列中OR 0.467(95%CI 0.228-0.954,P=.0367)。
  • O血型OR 1.42(95%CI 1.26-1.61,P=3.09×10-8)。
  • 荟萃分析表明ABO关联独立于PF4/肝素IgG水平,且功能试验阳性病例与抗体阳性(功能试验阴性)对照比较时强于与抗体阴性对照比较。

关键数值与推荐

  • 发现队列显著性阈值α=5×10-8,复制队列显著性阈值α=0.05。
  • rs8176719被确定为因果单核苷酸多态性(SNP)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Heparin-induced thrombocytopenia (HIT) is an unpredictable, potentially catastrophic adverse effect resulting from an immune response to platelet factor 4 (PF4)/heparin complexes. We performed a genome-wide association study (GWAS) with positive functional assay as the outcome in a large discovery cohort of patients divided into 3 groups: (1) functional assay-positive cases (n = 1269), (2) antibody-positive (functional assay-negative) controls (n = 1131), and (3) antibody-negative controls (n = 1766). Significant associations (α = 5 × 10-8) were investigated in a replication cohort (α = 0.05) of functional assay-confirmed HIT cases (n = 177), antibody-positive (function assay-negative) controls (n = 258), and antibody-negative controls (n = 351). We observed a strong association for positive functional assay with increasing PF4/heparin immunoglobulin-G (IgG) level (odds ratio [OR], 16.53; 95% confidence interval [CI], 13.83-19.74; P = 1.51 × 10-209) and female sex (OR, 1.15; 95% CI, 1.01-1.32; P = .034). The rs8176719 C insertion variant in ABO was significantly associated with positive functional assay status in the discovery cohort (frequency = 0.41; OR, 0.751; 95% CI, 0.682-0.828; P = 7.80 × 10-9) and in the replication cohort (OR, 0.467; 95% CI, 0.228-0.954; P = .0367). The rs8176719 C insertion, which encodes all non-O blood group alleles, had a protective effect, indicating that the rs8176719 C deletion and the O blood group were risk factors for HIT (O blood group OR, 1.42; 95% CI, 1.26-1.61; P = 3.09 × 10-8). Meta-analyses indicated that the ABO association was independent of PF4/heparin IgG levels and was stronger when functional assay-positive cases were compared with antibody-positive (functional assay-negative) controls than with antibody-negative controls. Sequencing and fine-mapping of ABO demonstrated that rs8176719 was the causal single nucleotide polymorphism (SNP). Our results clarify the biology underlying HIT pathogenesis with ramifications for prediction and may have important implications for related conditions, such as vaccine-induced thrombotic thrombocytopenia.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Karnes JH, Rollin J, Giles JB, et al. ABO O blood group as a risk factor for platelet reactivity in heparin-induced thrombocytopenia. Blood. 2022. PMID: 35377938. doi:10.1182/blood.2021014240

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。